Exchange: NSE·Updated 04:00 PM GMT+5:30
News
all
press releases
Exide sees marginal rise in Q4 net profit
Kolkata: Exide Industries reported a marginal rise in Q4 net profit to Rs 312 crore from Rs 255 crore a year ago, while revenue increased from Rs 4,15.
cityfalcon.com
More News
Best Battery Sector Stocks in India for 2026 Investment Guide
Battery sector stocks in India guide: battery sector growth via electric vehicles, with insights on Exide Industries and HBL Engineering for smart investing decisions.
cityfalcon.com
Brief India: US Semiconductor China Export Restrictions. Game, Set & Now Let's Try MATCH! and more
In this briefing: US Semiconductor China Export Restrictions. Game, Set & Now Let's Try MATCH! Exencial Industry Tidings - 27-04-2026 APAC Healthcare Weekly (April 26) – Sino Bio, Wuxi Bio, Astellas Pharma, Eisai, Celltrion, Cochlear HDFC Bank (HDFCB IN) Vs. Yes Bank (YES IN): Large–Small Bank Spread Signals Statistical Arbitrage Primer: Exide Industries (EXID IN) - Apr 2026 1. US Semiconductor China Export Restrictions. Game, Set & Now Let's Try MATCH! On April 2, 2026, a bipartisan group of US lawmakers introduced H.R. 8170, the Multilateral Alignment of Technology Controls on Hardware Act, or the MATCH Act. Three weeks later, on April 22, the House Foreign Affairs Committee advanced it in what lawmakers called ”the largest significant export control mark-up in the history of Congress.” If enacted, the immersion DUV ban will deal a serious blow to China's semiconductor ambitions in the medium term. It will also greatly accelerate Chinese efforts to develop their own... 2. Exencial Industry Tidings - 27-04-2026 Revenues of Reliance Consumer Products double to Rs.220 bln in 2025-26 Govt likely to keep prices of fertilisers unchanged, subsidy to remain high India EV market shifts toward mid-priced vehicles as entry segment declines 3.
cityfalcon.com
Brief India: Exencial Industry Tidings - 27-04-2026 and more
In this briefing: Exencial Industry Tidings - 27-04-2026 APAC Healthcare Weekly (April 26) – Sino Bio, Wuxi Bio, Astellas Pharma, Eisai, Celltrion, Cochlear HDFC Bank (HDFCB IN) Vs. Yes Bank (YES IN): Large–Small Bank Spread Signals Statistical Arbitrage Primer: Exide Industries (EXID IN) - Apr 2026 Primer: Delta Manufacturing (DELTAMAG IN) - Apr 2026 1. Exencial Industry Tidings - 27-04-2026 Revenues of Reliance Consumer Products double to Rs.220 bln in 2025-26 Govt likely to keep prices of fertilisers unchanged, subsidy to remain high India EV market shifts toward mid-priced vehicles as entry segment declines 2. APAC Healthcare Weekly (April 26) – Sino Bio, Wuxi Bio, Astellas Pharma, Eisai, Celltrion, Cochlear Sino Biopharmaceutical received approval for Benmelstobart plus Anlotinib for alveolar soft part sarcoma in China. Wuxi Biologics announced that three of its manufacturing facilities received GMP certification from South Korea. Astellas Pharma has been granted Priority Review status by the FDA for indication expansion application for Padcev.
cityfalcon.com
Brief India: APAC Healthcare Weekly (April 26) – Sino Bio, Wuxi Bio, Astellas Pharma, Eisai, Celltrion, Cochlear and more
In this briefing: APAC Healthcare Weekly (April 26) – Sino Bio, Wuxi Bio, Astellas Pharma, Eisai, Celltrion, Cochlear HDFC Bank (HDFCB IN) Vs. Yes Bank (YES IN): Large–Small Bank Spread Signals Statistical Arbitrage Primer: Exide Industries (EXID IN) - Apr 2026 Primer: Delta Manufacturing (DELTAMAG IN) - Apr 2026 Primer: Zen Technologies (ZEN IN) - Apr 2026 1. APAC Healthcare Weekly (April 26) – Sino Bio, Wuxi Bio, Astellas Pharma, Eisai, Celltrion, Cochlear Sino Biopharmaceutical received approval for Benmelstobart plus Anlotinib for alveolar soft part sarcoma in China. Wuxi Biologics announced that three of its manufacturing facilities received GMP certification from South Korea. Astellas Pharma has been granted Priority Review status by the FDA for indication expansion application for Padcev. Eisai’s Phase 3 trial evaluating Lenvima in RCC did not meet primary endpoints. Celltrion started patient dosing for three of its novel ADC-based anticancer drug candidates. Cochlear has reduced FY26 underlying net profit guidance to A$290–330M from A$435–460M. 2.
cityfalcon.com
Brief India: HDFC Bank (HDFCB IN) Vs. Yes Bank (YES IN): Large–Small Bank Spread Signals Statistical Arbitrage and more
In this briefing: HDFC Bank (HDFCB IN) Vs. Yes Bank (YES IN): Large–Small Bank Spread Signals Statistical Arbitrage Primer: Exide Industries (EXID IN) - Apr 2026 Primer: Delta Manufacturing (DELTAMAG IN) - Apr 2026 Primer: Zen Technologies (ZEN IN) - Apr 2026 Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 1. HDFC Bank (HDFCB IN) Vs. Yes Bank (YES IN): Large–Small Bank Spread Signals Statistical Arbitrage Context: The Yes Bank (YES IN) vs. HDFC Bank (HDFCB IN) price ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity. Highlight: Going long HDFC Bank (HDFCB IN) and short Yes Bank (YES IN) targets a 7% return. Why Read: Essential for quantitative traders seeking mean-reversion opportunities, with detailed execution framework, risk management protocols, and historical simulation showing the statistical basis for this relative value play. 2. Primer: Exide Industries (EXID IN) - Apr 2026 Exide Industries is India's largest lead-acid battery manufacturer, strategically pivoting towards lithium-ion (Li-ion) cell production to capitalize on the electric vehicle (EV) and renewable energy storage boom.
cityfalcon.com
Brief Growth Ideas: Primer: Kratos Defense & Security (KTOS US) - Apr 2026 and more
In this briefing: Primer: Kratos Defense & Security (KTOS US) - Apr 2026 Primer: Exide Industries (EXID IN) - Apr 2026 Primer: Delta Manufacturing (DELTAMAG IN) - Apr 2026 Primer: Kaonavi Inc (4435 JP) - Apr 2026 AI Infrastructure: Value Shifts to the Server Board Level 1. Primer: Kratos Defense & Security (KTOS US) - Apr 2026 Kratos is uniquely positioned as a 'disruptive prime' contractor, capitalizing on the paradigm shift in U.S. military strategy from high-cost, single-use platforms towards 'attritable mass'—large quantities of low-cost, autonomous, and expendable systems. The company's leadership in high-performance unmanned aerial systems (UAS), exemplified by the XQ-58A Valkyrie, aligns directly with key Department of Defense (DoD) modernization priorities, including the 'Replicator' initiative, driving strong revenue growth and a significant backlog. Despite a compelling strategic position and robust top-line growth, Kratos faces significant risks, including a high valuation, persistent negative free cash flow due to heavy R&D and capital expenditures, and a heavy reliance on U.S. government contracts, which are subject to budgetary and political shifts.
cityfalcon.com
Brief Equities Bottom-Up: Marvell Technologies Acquisition Strategy Signals A Massive Optical Disruption Ahead! and more
In this briefing: Marvell Technologies Acquisition Strategy Signals A Massive Optical Disruption Ahead! SoundHound AI Takeover Ambition: Why LivePerson Could Change Everything! Primer: Exide Industries (EXID IN) - Apr 2026 Primer: Delta Manufacturing (DELTAMAG IN) - Apr 2026 Primer: Kaonavi Inc (4435 JP) - Apr 2026 1. Marvell Technologies Acquisition Strategy Signals A Massive Optical Disruption Ahead! Marvell Technology, Inc. has moved to strengthen its optical connectivity roadmap through the acquisition of Polariton Technologies, a specialist in high-speed, low-power plasmonics-based silicon photonics devices. The deal, announced on April 22, 2026, comes as AI workloads continue to push data center bandwidth requirements higher, forcing cloud and infrastructure customers to look beyond today’s 1.6T optical connectivity standards toward 3.2T and beyond. Polariton brings advanced modulation technology designed for compact, energy-efficient optical signaling across coherent, ZR, ZR+, scale-across, and data center interconnect applications. 2.
cityfalcon.com
Brief Equities Bottom-Up: SoundHound AI Takeover Ambition: Why LivePerson Could Change Everything! and more
In this briefing: SoundHound AI Takeover Ambition: Why LivePerson Could Change Everything! Primer: Exide Industries (EXID IN) - Apr 2026 Primer: Delta Manufacturing (DELTAMAG IN) - Apr 2026 Primer: Kaonavi Inc (4435 JP) - Apr 2026 SK Hynix Q126 Earnings Call Transcript 1. SoundHound AI Takeover Ambition: Why LivePerson Could Change Everything! SoundHound AI has entered a new phase of strategic ambition after reporting record 2025 results, guiding for another year of strong growth in 2026, and then moving to acquire LivePerson for $43 million in equity value in a transaction that implies roughly $250 million of enterprise value after debt discounts. The proposed combination arrives as SoundHound is scaling its agentic AI platform across automotive, restaurants, enterprise customer service, voice commerce, and connected devices, while also pursuing a more disciplined path toward breakeven. Management has been emphasizing broader enterprise traction, higher containment rates, stronger deal velocity, and the ability to deploy one AI framework across multiple touchpoints. 2.
cityfalcon.com
Brief Equities Bottom-Up: Primer: Exide Industries (EXID IN) - Apr 2026 and more
In this briefing: Primer: Exide Industries (EXID IN) - Apr 2026 Primer: Delta Manufacturing (DELTAMAG IN) - Apr 2026 Primer: Kaonavi Inc (4435 JP) - Apr 2026 SK Hynix Q126 Earnings Call Transcript IBM Q1 2026. Solid Beats But Prudent Guidance Gets Punished. 1. Primer: Exide Industries (EXID IN) - Apr 2026 Exide Industries is India's largest lead-acid battery manufacturer, strategically pivoting towards lithium-ion (Li-ion) cell production to capitalize on the electric vehicle (EV) and renewable energy storage boom. The company is undertaking significant capital expenditure to establish a 12 GWh Li-ion cell manufacturing plant through its subsidiary, Exide Energy Solutions Ltd. (EESL), which presents a substantial long-term growth opportunity but also carries execution risk and is expected to suppress free cash flow in the near term. While maintaining a dominant position in the profitable lead-acid aftermarket, which provides stable cash flows, the company faces increasing competition in the emerging Li-ion space and margin pressures from raw material price volatility.
cityfalcon.com

Advertisement|Remove ads.